FIRST MANHATTAN CO. LLC. - AQUESTIVE THERAPEUTICS INC ownership

AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 48 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.97 and the average weighting 1.9%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of AQUESTIVE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$902
-9.8%
1,0000.0%0.00%
Q3 2022$1,0000.0%1,000
-50.0%
0.00%
Q2 2022$1,000
-80.0%
2,0000.0%0.00%
Q1 2022$5,000
-28.6%
2,0000.0%0.00%
Q4 2021$7,000
-12.5%
2,0000.0%0.00%
Q3 2021$8,000
-20.0%
2,000
-23.1%
0.00%
Q2 2021$10,000
+400.0%
2,600
+333.3%
0.00%
Q3 2020$2,000
+100.0%
600
+100.0%
0.00%
Q2 2020$1,0003000.00%
Other shareholders
AQUESTIVE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Bratton Capital Management, L.P. 11,503,294$55,848,00077.67%
Bracebridge Capital, LLC 428,571$2,083,0000.33%
Oak Grove Capital LLC 89,000$432,0000.20%
Perceptive Advisors 1,750,000$8,496,0000.12%
Virtu Financial LLC 117,206$569,0000.10%
WEDBUSH SECURITIES INC 103,240$501,0000.05%
J. Goldman & Co LP 117,600$571,0000.04%
Engineers Gate Manager LP 68,300$332,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 118,900$577,0000.01%
Brandywine Global Investment Management, LLC 137,029$666,0000.01%
View complete list of AQUESTIVE THERAPEUTICS INC shareholders